Tuberculosis Flashcards

1
Q

Risk factors for TB

A
  • Homeless populations
  • Incarcerated population
  • HIV/AIDS clients - Leading killer of people with HIV infection
  • Immunosuppressed clients
  • Children younger than 5 or older adults
  • Malnourished populations
  • Alcohol abusers & IV drug users
  • Drinking unpasteurized milk from infected cows
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

All of the following are risk factors for what?

Homeless populations
Incarcerated population
HIV/AIDS clients
Leading killer of people with HIV infection
Immunosuppressed clients
Children younger than 5 or older adults
Malnourished populations
Alcohol abusers & IV drug users
Drinking unpasteurized milk from infected cows

A

TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 4 types of TB

A
  • Latent TB Infection
  • Primary TB Infection
  • Primary Progressive (Symptomatic) TB Infection
  • Multi Drug-Resistant TB infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of TB is this?

  • No symptoms
  • Not contagious
A

Latent TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for LTBI

A
  • HIV infection
  • Long-term diabetes
  • Chronic renal disease
  • Long-term steroid administration
  • Sepsis
  • Malnutrition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The following are S/S of what?

  • Fatigue, lethargy
  • Weight Loss, anorexia
  • Low grade fever
  • Night Sweats, chills
  • Persistent cough with blood-tinged sputum
  • Chest tightness & dull, aching chest pain
  • Dyspnea, orthopnea, & rales as disease progresses
A

Primary Progressive TB Infection

Symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is primary TB infectious? asymptomatic?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Expected inflammatory response in TB patients

A

Unexplained weight loss
night sweats
fever
chills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What type of TB is this?

Resistant to one or more of the first line medications used for the treatment of TB

A

Drug resistant Mycobacterium Tuberculosis

MDR TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

After a positive skin test is observed what needs to be done and why?

A

CXR to rule out active TB or to detect old, healed lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When should a PPD skin test should be read?

A

48-72 hrs after administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you administer a PPD skin test with

A
  • with a 1/4-1/2 in 27 g needle
  • 0.1 mL of PPD
  • intradermally into forearm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Priority Nursing assessments for TB patients

A

Assess lung sounds (may hear wheezing or decreased sounds)
Assess oxygen saturation (indicates effectiveness of tissue perfusion)
Assess temperature (expect low grade fever with TB)
Assess sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tests used to dx TB

A
  • Sputum Culture
  • TB Skin test
  • CXR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment goals for TB patients

A
  • Cure the patient
  • Minimize disease transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What medication is this?

Classification: Antitubercular Drug
Actions: Bactericidal, stops growth of TB organism
Contraindications:
Do not use in clients with acute liver disease or hypersensitivity
Use with caution in clients with renal impairment and ETOH use
Use with caution in clients taking Dilantin
S/E: Peripheral neuritis, Neurotoxicity, hepatotoxicity/hepatitis, N/V, Dry mouth, Hyperglycemia, Vision changes

Used to treat TB

A

Isoniazid (INH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Contraindications for Isoniazid

A
  • Do not use in clients with acute liver disease or hypersensitivity
  • Use with caution in clients with renal impairment and ETOH use
  • Use with caution in clients taking Dilantin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name S/E of Isoniazid

A
  • Peripheral neuritis
  • Neurotoxicity
  • hepatotoxicity/hepatitis
  • N/V
  • Dry mouth
  • Hyperglycemia
  • Vision changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

S/S of neuritis

A
  • tingling
  • numbness
  • burning of the extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

S/S of Hepatitis

A
  • anorexia
  • N/V
  • weakness
  • fatigue
  • dark urine
  • jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

S/S of hepatoxicity

A
  • fever
  • anorexia
  • malaise
  • N/V
  • darkened urine
  • yellowish discoloration of skin and eyes
  • pain and swelling of the joints occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The following are what types of foods?

  • Cured, smoked, or processed meats
  • Pickled veggies
  • Soy sauce
  • smoked aged cheese
  • beer
A

Tyramine containing foods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nursing interventions for Isoniazid (INH)

A
  • Assess for hypersensitivity
  • Monitor for S/S of hepatitis:
  • Monitor for S/S of neuritis:
  • Assess mental status and vision changes
  • Monitor glucose levels
  • Administer medication 1hr before or 2hrs after meals to avoid delayed absorption
  • Administer at least 1hr before antacids
  • Pyridoxine (Vitamin B-6) to reduce risk of neurotoxicity
24
Q

How to reduce the risk of neurotoxicity in patients taking isoniazid

A

Pyridoxine or Vitamin B-6

25
Q

S/S of hypersensitivity rxn

A

Fever
Chills
Headache
Muscle and bone pain
Dyspnea

26
Q

What medication is this?

Classification: Antibiotic
Actions: Bactericidal, stops growth of bacteria by inhibiting RNA synthesis
Contraindications:
Do not use in clients with hypersensitivity
Use with caution in clients with liver impairment and ETOH use
Use with caution in clients taking anticoagulants, hypoglycemics, digoxin, antifungals, dilantin, and some cardiac meds
S/E: Hypersensitivity reaction, heartburn, N/V/D, red-orange colored body secretions, hepatitis/hepatotoxicity, increased uric acid levels, blood dyscrasias, colitis

used to treat TB

A

Rifampin (Rifadin)

27
Q

S/E of Rifampin

A
  • Hypersensitivity reaction
  • heartburn
  • N/V/D
  • red-orange colored body secretions hepatitis/hepatotoxicity
  • increased uric acid levels
  • blood dyscrasias
  • colitis
28
Q

Contraindications for rifampin

A
  • Do not use in clients with hypersensitivity
  • Use with caution in clients with liver impairment and ETOH use
  • Use with caution in clients taking anticoagulants, hypoglycemics, digoxin, antifungals, dilantin, and some cardiac meds
29
Q

S/S of Colitis

A
  • colicky abdominal pain
  • urgency
  • diarrhea
  • tenesmus (continual/recurrent feeling of needing to poop)
30
Q

continual/recurrent feeling of needing to poop

A

tenesmus

31
Q

Nursing Interventions for rifampin

A
  • Assess for hypersensitivity
  • Monitor LFTs, APTT, PTNINR and uric acid levels
  • Assess for S/S of hepatitis
  • Assess for S/S of colitis
32
Q

Client education about rifampin

A
  • Urine, feces, sweat, and tears will be red-orange colored
  • Soft contact lenses can become permanently discolored, as well as other items
  • Notify PCP if jaundice develops or any unusual bleeding occurs
33
Q

Teaching for patients taking ethambutol or myambutol

A

o Contradicted in patients with renal impairment, hepatic impairment, hypersensitivity and Optic neuritis
o Assess visual function during therapy, report any blurry vision or constriction
o Assess lung sounds and character of sputum periodically during therapy
o Monitor renal and hepatic functions, CBC and uric acid levels routinely.
o At risk for gout d/t increased uric acid levels.
o Administer with food or milk to avoid GI irritation
o Notify PCP if improvement in cough is not seen in 2-3 weeks

34
Q

Teaching for patients takes pyrazinamide

A

o Inform patient with diabetes that medication may interfere with urine ketone measurements
o Notify PCP if no improvement after 2-3 weeks of therapy.
o Report any fever, anorexia, malaise, N/V, darkened urine, yellowish discoloration of skin and eyes, pain and swelling of the joints occurs.
o Advise to wear sunscreen and protective clothing
o Monitor hepatic function before and every 2-4 week during therapy. (AST and ALT may come back normal)
o Monitor serum uric acid concentrations, urine ketones
o Patients w/ impaired liver function should receive Pyrazinamide treatment only
o This medication may be given w/ Isoniazid

35
Q

How to determine if TB is being treated adequately?

A

Collect sputum cultures every 2-4 weeks after 3-4 negative sputums they are considered no lonfer infectious and can resume normal activities

36
Q

Rifampin will stain what red/orange?

A
  • urine
  • feces
  • sweat
  • tears
  • contact lenses
37
Q

Labs to monitor for rifampin

A

CBC
PT/INR
PTT
Uric Acid (for gout)

38
Q

Labs to monitor for Ethambutol or myambutol

A
  • Reanal function
  • Hepatic function
  • CBC
  • Uric acid
39
Q

When taking Ethabutol(Myambutol) and Pyrazinamide(Tebrazid) how long after initiation of therapy should improvement be seen and what should be done?

A

Cough should stop within 2-3 weeks if not call PCP

40
Q

What should Ethambutol or Myambutol should be given with what and why?

A

Milk to avoid GI irritation

41
Q

Labs to monitor for Pyrazinamide or Tebrazid

A

Hepatic function (every 2-4 wks during and every 2-4 wks after)
Uric acid
Urine ketones

42
Q

Pyrazinamide can be given with what medication?

A

Isoniazid

43
Q

Patients on Pyrazinamide should be taught to do what to prevent gout and kidney problems?

A

Increase fluids

44
Q

How to collect sputum samples

A
  • Collect in early morning
  • Obtain in negative airflow room
  • Give breathing ttmnt first if it is prescribed.
  • rinse mouth before
  • obtain every 2-3 weeks
  • 3-4 negative sputums are needed to declare patient non-infectious and regular activities can be resumed.
45
Q

S/S of Neurotoxicity

A
  • Muscle numbness
  • seizures
  • tingling
  • twitching
46
Q

PPD Induration that is positive in this population?

  • HIV-infected persons
  • Recent contact with TB infected client
  • Clients with fibrotic changes of CXR
  • Clients with organ transplants
  • Immunosuppressed clients
A

> 5 mm

47
Q

A PPD test with an induration of > 5mm is positive in what kinds of patients?

A
  • HIV-infected persons
  • Recent contact with TB infected client
  • Clients with fibrotic changes of CXR
  • Clients with organ transplants
  • Immunosuppressed clients
48
Q

PPD Induration that is positive in this population?

Any person, including people with no known risk factor for TB

A

> 15 mm

49
Q

PPD Induration that is positive in this population?

  • Recent immigrants from high prevelance TB countries
  • IV drug users
  • People in crowded living facilities
  • Mycobacteriology lab personnel
  • Staff with high exposure risks
  • Children < 4 yrs old
  • Infants children, adolescents exposed in high-risk categories
A

> 10 mm

50
Q

A PPD test with an induration > 10 mm is positive in what kinds of patients?

A
  • Recent immigrants from high prevelance TB countries
  • IV drug users
  • People in crowded living facilities
  • Mycobacteriology lab personnel
  • Staff with high exposure risks
  • Children < 4 yrs old
  • adolescents exposed in high-risk categories
51
Q

In what kinds of patients would a PPD test with an induration of > 15 mm be positive?

A

Any person including people with no know risk factor

52
Q

Contraindications for ethambutol or myambutol

A

patients with renal impairment, hepatic impairment, hypersensitivity and Optic neuritis

53
Q

Diabetic patients taking pyrazinamide should me taught to what?

A

monitor their blood sugar closely

54
Q

Complications r/t TB

A
  • Respiratory failure
  • Bronchopleural fistula
  • Pleural effusions
  • Meningitis
  • Lymphadenopathy
  • Bone disease
  • Liver failure
  • Kidney failure
55
Q

an abnormal pathway or sinus tract that develops between the bronchus and the pleural space

a complication of TB

A

Bronchopleural fistula

56
Q

Coughing hygiene for TB patients

A

cover mouth AND nose, dispose of used tissue into plastic bags

57
Q

Nutrition teaching for TB patients

A

foods rich in iron, protein, and vitamin C is a must